Dentsply Sirona reported a decrease in net sales for Q1 2025, driven by a decline in the United States and Orthodontic and Implant Solutions segment. Despite the sales challenges, the company saw improvements in adjusted EBITDA margin and maintained its full-year adjusted EPS outlook.
Net sales for Q1 2025 were $879 million, a decrease of 7.7% compared to Q1 2024.
GAAP net income was $20 million, or $0.10 per share, a slight increase from $18 million or $0.09 per share in Q1 2024.
Adjusted EPS was $0.43, up from $0.42 in the prior year quarter.
The company maintained its full-year 2025 outlook for organic sales and adjusted EPS, while increasing reported sales outlook due to foreign exchange changes.
Dentsply Sirona is maintaining its 2025 outlook for organic sales and adjusted EPS, while increasing its reported sales range due to foreign exchange rate changes.
Visualization of income flow from segment revenue to net income